(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 68.04%163.5M | -64.68%-149.2M | 15.04%351.8M | 13.78%128M | 25.49%217.1M | -14.42%97.3M | 3.00%-90.6M | 305.8M | 112.5M | 173M |
Net income from continuing operations | 49.52%141.3M | 5.26%140.2M | 310.54%467.2M | 34.90%303.8M | -246.80%-64.3M | 187.74%94.5M | 380.42%133.2M | --113.8M | --225.2M | --43.8M |
Operating gains losses | -135.35%-11.7M | 75.40%-22.8M | -134.01%-149.8M | -1,235.76%-220.4M | 167.11%100.7M | -85.33%33.1M | -147.88%-92.7M | --440.5M | ---16.5M | --37.7M |
Securities amortization | -97.44%-7.7M | -132.26%-7.2M | -319.05%-18.4M | -276.47%-6.4M | -600.00%-5M | -214.71%-3.9M | -154.39%-3.1M | --8.4M | ---1.7M | --1M |
Unrealized gains and losses of investment securities | -90.17%2.9M | ---- | ---- | ---- | ---- | --29.5M | ---- | ---- | ---- | ---- |
Remuneration paid in stock | 10.71%6.2M | -26.67%3.3M | -1.91%20.5M | 0.00%5.8M | -25.81%4.6M | 21.74%5.6M | 4.65%4.5M | --20.9M | --5.8M | --6.2M |
Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---67M | ---- | ---- |
Change in working capital | 152.53%43.6M | -0.59%-154M | 16.83%-138.9M | 27.38%-37.4M | 97.94%134.6M | -1,120.59%-83M | 13.36%-153.1M | ---167M | ---51.5M | --68M |
-Change in loss and loss adjustment expense reserves | 149.39%40.5M | -3.68%-118.3M | 8.00%-83.9M | 43.54%-34.1M | 28.45%146.3M | -806.90%-82M | 27.00%-114.1M | ---91.2M | ---60.4M | --113.9M |
-Change in reinsurance recoverable on paid and unpaid losses | -57.81%5.4M | 138.38%3.8M | 62.07%-25.3M | -131.13%-24.5M | 93.03%-3.7M | 152.67%12.8M | -146.48%-9.9M | ---66.7M | ---10.6M | ---53.1M |
-Change in payables and accrued expense | -129.87%-2.3M | -47.52%-35.7M | -5,100.00%-15M | 22.99%10.7M | -171.88%-9.2M | 220.83%7.7M | -2.54%-24.2M | --300K | --8.7M | --12.8M |
-Change in other current assets | --0 | 22.45%-3.8M | -56.38%-14.7M | -2.78%10.5M | 121.43%1.2M | -714.29%-21.5M | 72.93%-4.9M | ---9.4M | --10.8M | ---5.6M |
Tax refund paid | -847.73%-41.7M | -3,902.86%-140.1M | 155.99%65.4M | 1,358.14%54.1M | 2,500.00%19.2M | 80.53%-4.4M | 96.07%-3.5M | ---116.8M | ---4.3M | ---800K |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | 68.04%163.5M | -64.68%-149.2M | 15.04%351.8M | 13.78%128M | 25.49%217.1M | -14.42%97.3M | 3.00%-90.6M | --305.8M | --112.5M | --173M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 54.53%-61.8M | 38.76%105.6M | 6.08%-351.9M | -10.77%-310.6M | 205.11%18.5M | -113.34%-135.9M | 685.38%76.1M | 64.12%-374.7M | 29.07%-280.4M | 89.87%-17.6M |
Net intangibles purchase and sale | 26.75%-11.5M | -6.71%-30.2M | 3.63%-87.5M | 14.71%-17.4M | -41.08%-26.1M | 34.31%-15.7M | -1.07%-28.3M | ---90.8M | ---20.4M | ---18.5M |
Net business purchase and sale | 85.67%-26.2M | -619.51%-59M | -69.13%-409.3M | 8.94%-206.7M | ---11.6M | -1,118.67%-182.8M | ---8.2M | ---242M | ---227M | --0 |
Net investment purchase and sale | -140.03%-24.7M | 73.26%194.4M | 379.52%151.5M | -144.10%-86.9M | 1,008.45%64.5M | 301.63%61.7M | 487.43%112.2M | 94.62%-54.2M | 91.08%-35.6M | 95.35%-7.1M |
Net proceeds payment for loan | -33.33%600K | 0.00%400K | -153.66%-6.6M | -84.62%400K | -203.75%-8.3M | -84.48%900K | 109.76%400K | -7.52%12.3M | -74.76%2.6M | 700.00%8M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 54.53%-61.8M | 38.76%105.6M | 6.08%-351.9M | -10.77%-310.6M | 205.11%18.5M | -113.34%-135.9M | 685.38%76.1M | 64.12%-374.7M | 29.07%-280.4M | 89.87%-17.6M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -346.21%-103.9M | 267.20%62.2M | -183.11%-61M | -4.08%-38.3M | 21.97%-27.7M | -74.90%42.2M | -66.07%-37.2M | -80.52%73.4M | -109.77%-36.8M | -35.5M |
Net issuance payments of debt | -165.88%-50.2M | --0 | 7,620.00%75.2M | --0 | --0 | --76.2M | ---1M | ---1M | ---1M | --0 |
Net common stock issuance | ---15.2M | 16.33%-4.1M | 74.07%-13.9M | 31.82%-9M | --0 | --0 | 39.51%-4.9M | -102.35%-53.6M | -100.58%-13.2M | ---12.5M |
Cash dividends paid | -16.46%-18.4M | -17.09%-18.5M | 0.16%-63.2M | -9.79%-15.7M | -11.19%-15.9M | -9.72%-15.8M | 22.17%-15.8M | ---63.3M | ---14.3M | ---14.3M |
Net other financing charges | -10.44%-20.1M | 647.10%84.8M | -130.89%-59.1M | -63.86%-13.6M | -35.63%-11.8M | -109.00%-18.2M | -358.33%-15.5M | 110.02%191.3M | ---8.3M | ---8.7M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -346.21%-103.9M | 267.20%62.2M | -183.11%-61M | -4.08%-38.3M | 21.97%-27.7M | -74.90%42.2M | -66.07%-37.2M | -80.52%73.4M | -109.77%-36.8M | ---35.5M |
Net cash flow | ||||||||||
Beginning cash position | 2.04%460.1M | -12.16%441.5M | 0.90%502.6M | -6.35%662.4M | -22.63%454.5M | 22.10%450.9M | 0.90%502.6M | -2.39%498.1M | 108.09%707.3M | 128.21%587.4M |
Current changes in cash | -161.11%-2.2M | 135.98%18.6M | -1,457.78%-61.1M | -7.91%-220.9M | 73.39%207.9M | -98.35%3.6M | 59.86%-51.7M | 136.89%4.5M | -229.39%-204.7M | 45.33%119.9M |
End cash Position | 0.75%457.9M | 2.04%460.1M | -12.16%441.5M | -12.16%441.5M | -6.35%662.4M | -22.63%454.5M | 22.10%450.9M | 0.90%502.6M | 0.90%502.6M | 108.09%707.3M |
Free cash flow | 86.27%152M | -50.88%-179.4M | 22.93%264.3M | 20.09%110.6M | 23.62%191M | -9.13%81.6M | 2.06%-118.9M | -67.19%215M | -47.88%92.1M | -39.70%154.5M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.